Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay.

Vasile VC, Saenger AK, Kroning JM, Jaffe AS.

Clin Chem. 2010 Jul;56(7):1086-90. doi: 10.1373/clinchem.2009.140616. Epub 2010 May 14.

2.

Validation of the health ABC heart failure model for incident heart failure risk prediction: the Cardiovascular Health Study.

Kalogeropoulos A, Psaty BM, Vasan RS, Georgiopoulou V, Smith AL, Smith NL, Kritchevsky SB, Wilson PW, Newman AB, Harris TB, Butler J; Cardiovascular Health Study.

Circ Heart Fail. 2010 Jul;3(4):495-502. doi: 10.1161/CIRCHEARTFAILURE.109.904300. Epub 2010 Apr 28.

3.

Cardiovascular risk prediction: basic concepts, current status, and future directions.

Lloyd-Jones DM.

Circulation. 2010 Apr 20;121(15):1768-77. doi: 10.1161/CIRCULATIONAHA.109.849166. Review. No abstract available.

4.

Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.

deFilippi CR, Christenson RH, Gottdiener JS, Kop WJ, Seliger SL.

J Am Coll Cardiol. 2010 Feb 2;55(5):441-50. doi: 10.1016/j.jacc.2009.07.069.

5.

Analytical validation of a high-sensitivity cardiac troponin T assay.

Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA.

Clin Chem. 2010 Feb;56(2):254-61. doi: 10.1373/clinchem.2009.132654. Epub 2009 Dec 3.

6.

A sensitive cardiac troponin T assay in stable coronary artery disease.

Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, Pfeffer MA, Braunwald E; Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators.

N Engl J Med. 2009 Dec 24;361(26):2538-47. doi: 10.1056/NEJMoa0805299. Epub 2009 Nov 25.

7.

B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies.

Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, Thompson A, Gudnason V, Sattar N, Danesh J.

Circulation. 2009 Dec 1;120(22):2177-87. doi: 10.1161/CIRCULATIONAHA.109.884866. Epub 2009 Nov 16. Review.

8.

Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.

Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engström G, Persson M, Smith JG, Magnusson M, Christensson A, Struck J, Morgenthaler NG, Bergmann A, Pencina MJ, Wang TJ.

JAMA. 2009 Jul 1;302(1):49-57. doi: 10.1001/jama.2009.943.

9.

Predicting the 30-year risk of cardiovascular disease: the framingham heart study.

Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan RS.

Circulation. 2009 Jun 23;119(24):3078-84. doi: 10.1161/CIRCULATIONAHA.108.816694. Epub 2009 Jun 8.

10.

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association.

Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE Jr, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC Jr, Wilson PW; American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council.

Circulation. 2009 May 5;119(17):2408-16. doi: 10.1161/CIRCULATIONAHA.109.192278. Epub 2009 Apr 13. Erratum in: Circulation. 2009 Jun 30;119(25):e606. Hong, Yuling [added].

11.

Rehospitalizations among patients in the Medicare fee-for-service program.

Jencks SF, Williams MV, Coleman EA.

N Engl J Med. 2009 Apr 2;360(14):1418-28. doi: 10.1056/NEJMsa0803563. Erratum in: N Engl J Med. 2011 Apr 21;364(16):1582.

12.

Cardiac troponin-I and risk of heart failure: a community-based cohort study.

Sundström J, Ingelsson E, Berglund L, Zethelius B, Lind L, Venge P, Arnlöv J.

Eur Heart J. 2009 Apr;30(7):773-81. doi: 10.1093/eurheartj/ehp047. Epub 2009 Mar 4.

PMID:
19264749
13.

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.

Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP; TIME-CHF Investigators.

JAMA. 2009 Jan 28;301(4):383-92. doi: 10.1001/jama.2009.2.

PMID:
19176440
14.

Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35.

Sabatine MS, Morrow DA, de Lemos JA, Jarolim P, Braunwald E.

Eur Heart J. 2009 Jan;30(2):162-9. doi: 10.1093/eurheartj/ehn504. Epub 2008 Nov 8.

15.

Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice.

Wu AH, Lu QA, Todd J, Moecks J, Wians F.

Clin Chem. 2009 Jan;55(1):52-8. doi: 10.1373/clinchem.2008.107391. Epub 2008 Nov 6.

16.

Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.

Daniels LB, Laughlin GA, Clopton P, Maisel AS, Barrett-Connor E.

J Am Coll Cardiol. 2008 Aug 5;52(6):450-9. doi: 10.1016/j.jacc.2008.04.033.

17.

Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects.

Eggers KM, Lind L, Ahlström H, Bjerner T, Ebeling Barbier C, Larsson A, Venge P, Lindahl B.

Eur Heart J. 2008 Sep;29(18):2252-8. doi: 10.1093/eurheartj/ehn327. Epub 2008 Jul 7.

PMID:
18606612
18.

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.

Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlöv J.

N Engl J Med. 2008 May 15;358(20):2107-16. doi: 10.1056/NEJMoa0707064.

19.

Universal definition of myocardial infarction.

Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernández-Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N.

Circulation. 2007 Nov 27;116(22):2634-53. Epub 2007 Oct 19. No abstract available.

20.

Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.

Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, Angelici L, Barlera S, Parrinello G, Maggioni AP, Tognoni G, Cohn JN; Val-HeFT Investigators.

Circulation. 2007 Sep 11;116(11):1242-9. Epub 2007 Aug 13.

Supplemental Content

Support Center